These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4171540)

  • 1. Acquired factor 8 antibodies: further immunologic and electrophoretic studies.
    Shapiro SS; Carroll KS
    Science; 1968 May; 160(3829):786-7. PubMed ID: 4171540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody nature of an AHG (factor 8) inhibitor.
    Lusher JM; Shuster J; Evans RK; Poulik MD
    J Pediatr; 1968 Mar; 72(3):325-31. PubMed ID: 4170637
    [No Abstract]   [Full Text] [Related]  

  • 3. [Factor VIII inhibitor-caused hemophilia].
    Peto I; Bánhegyi D; Nemesánszky E; Köves A; Sas G
    Orv Hetil; 1977 Sep; 118(36):2145-9. PubMed ID: 917507
    [No Abstract]   [Full Text] [Related]  

  • 4. [Development of inhibitors following long-term substitution of human antihemophilia globulin in severe hemophilia].
    Bläker F; Fischer K; Landbeck G
    Klin Wochenschr; 1967 Jun; 45(12):630-3. PubMed ID: 4186156
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibitors in haemophilia.
    Biggs R
    Bibl Haematol; 1970; 34():125-34. PubMed ID: 4191059
    [No Abstract]   [Full Text] [Related]  

  • 6. The rapid development of an IgM inhibitor of porcine factor VIII in a patient with acquired haemophilia.
    Weston Smith SG; Revell P; Lawrie AS; Holland LJ; Savidge GF
    Br J Haematol; 1990 Jul; 75(3):434-6. PubMed ID: 2117466
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunological analysis of acquired factor VIII inhibitor in a case with immunologic disorder.
    Okamura T; Yamauchi Y; Fukuda T; Suehiro K; Murakawa M; Shibuya T; Nagasawa K; Harada M; Niho Y
    Acta Haematol; 1991; 85(3):153-5. PubMed ID: 1710410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitors (antibodies) directed against factor VIII in hemophilia A (author's transl)].
    Beck EA
    Ther Umsch; 1979 Apr; 36(4):326-9. PubMed ID: 377556
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of coagulation factor VIII inhibitors].
    Lutze G; Schlote A; Mittler U
    Z Gesamte Inn Med; 1980 Apr; 35(8):330-6. PubMed ID: 6776700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunologic character of acquired inhibitors of antihemophilic globulin (factor 8) and the kinetics of their interaction with factor 8.
    Shapiro SS
    J Clin Invest; 1967 Feb; 46(2):147-56. PubMed ID: 6018754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolving role and future relevance of plasma-derived therapies in the management of bleeding disorders.
    Jiménez-Yuste V; Kruse-Jarres R; Rangarajan S; Altisent C
    Thromb Haemost; 2016 Aug; 116 Suppl 1():S1. PubMed ID: 27528277
    [No Abstract]   [Full Text] [Related]  

  • 12. [Factor VIII inhibitor in a patient with mild haemophilia A (author's transl)].
    Gastaldi G; Avanzi G; Saccon C; Galletti A
    Haematologica; 1975 Dec; 60(4):477-84. PubMed ID: 816717
    [No Abstract]   [Full Text] [Related]  

  • 13. Electrophoretic analysis of polypeptide chains isolated from antibodies in the serum of immunized rabbits.
    Miller EJ; Osterland CK; Davie JM; Krause RM
    J Immunol; 1967 Apr; 98(4):710-5. PubMed ID: 4164553
    [No Abstract]   [Full Text] [Related]  

  • 14. Gamma-G-antibody to human anti-hemophilic globulin (factor 8).
    Andersen BR; Troup SB
    J Immunol; 1968 Jan; 100(1):175-86. PubMed ID: 4170426
    [No Abstract]   [Full Text] [Related]  

  • 15. Acquired hemophilia.
    Shulman NR; Hirschman RJ
    Trans Assoc Am Physicians; 1969; 82():388-97. PubMed ID: 4192751
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of phospholipid on factor VIII inactivation.
    Barrowcliffe TW; Kemball-Cook G; Gray E
    Prog Clin Biol Res; 1984; 150():251-63. PubMed ID: 6431431
    [No Abstract]   [Full Text] [Related]  

  • 17. The prevalence of proteolytic antibodies against factor VIII in hemophilia A.
    Lacroix-Desmazes S; Bayry J; Misra N; Horn MP; Villard S; Pashov A; Stieltjes N; d'Oiron R; Saint-Remy JM; Hoebeke J; Kazatchkine MD; Reinbolt J; Mohanty D; Kaveri SV
    N Engl J Med; 2002 Feb; 346(9):662-7. PubMed ID: 11870243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful cyclosporin therapy of acquired hemophilia caused by factor VIII (VIII:C) inhibiting antibody].
    Pfliegler G; Boda Z; Hársfalvi J; Flóra-Nagy M; Sári B; Pecze K; Rák K
    Orv Hetil; 1991 Jul; 132(27):1485-8. PubMed ID: 1956679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of factor VIII inhibitors.
    Kasper CK
    Prog Hemost Thromb; 1989; 9():57-86. PubMed ID: 2492380
    [No Abstract]   [Full Text] [Related]  

  • 20. Tolerance to factor VIII inhibitors in hemophilia A patients: a French twist.
    Pascual V; Capra JD
    J Clin Invest; 1996 Mar; 97(6):1357-8. PubMed ID: 8617864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.